## Clinical Diagnosis The patient has **acute uncomplicated bacterial cystitis** (lower UTI) with pyuria, bacteriuria, dysuria, and suprapubic pain. The key clinical constraint is a **history of penicillin allergy (non-anaphylactic rash)**. Serum creatinine is 0.9 mg/dL (eGFR well above 30 mL/min), making nitrofurantoin safe to use. ## First-Line Therapy for Uncomplicated Cystitis **Key Point:** Per IDSA guidelines (Gupta et al., *CID* 2011) and standard pharmacology references (KD Tripathi, *Essentials of Medical Pharmacology*, 9th ed.), the **first-line agents for uncomplicated bacterial cystitis** are: 1. **Nitrofurantoin** (macrocrystalline) 100 mg twice daily × 5 days 2. Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily × 3 days (where resistance <20%) 3. Fosfomycin 3 g single dose Fluoroquinolones and cephalosporins are **not recommended as first-line** for uncomplicated cystitis to preserve their utility for more serious infections. ## Why Nitrofurantoin Is Correct **Clinical Pearl:** Nitrofurantoin is the **drug of choice** for uncomplicated cystitis in this patient because: 1. **Excellent urinary concentration** — achieves high levels in urine; minimal systemic absorption limits collateral resistance 2. **Broad coverage of common uropathogens** (*E. coli*, *Staphylococcus saprophyticus*, *Enterococcus*) 3. **Safe in non-anaphylactic penicillin allergy** — no cross-reactivity (completely different drug class) 4. **Normal renal function** (Cr 0.9 mg/dL, eGFR >60) — nitrofurantoin is contraindicated only when eGFR <30 mL/min 5. Short 5-day course minimizes risk of pulmonary/neuropathic adverse effects (which occur with prolonged use) ## Penicillin Allergy and Beta-Lactams **High-Yield:** The penicillin allergy history is a **distractor** in this question. While non-anaphylactic penicillin allergy carries <2% cross-reactivity with third-generation cephalosporins (making cefixime technically safe), cefixime is **not a first-line agent for uncomplicated cystitis** regardless of allergy status. The allergy does not change the preferred first-line choice here. ## Why Other Options Are Suboptimal | Agent | Reason Not Preferred | |---|---| | **TMP-SMX** | Acceptable alternative, but high *E. coli* resistance rates (>20%) in many Indian regions limit empiric use | | **Cefixime** | Third-generation cephalosporin; safe in non-anaphylactic penicillin allergy, but NOT a first-line agent for uncomplicated cystitis per IDSA/national guidelines | | **Ciprofloxacin** | Fluoroquinolones should be reserved for complicated UTI, pyelonephritis, or documented resistance; overuse drives resistance and is discouraged for uncomplicated cystitis | **Warning:** Choosing cefixime or ciprofloxacin for uncomplicated cystitis represents antibiotic stewardship failure — these agents should be preserved for more serious or resistant infections. **Reference:** IDSA Guidelines for Uncomplicated Cystitis (Gupta et al., *CID* 2011); KD Tripathi *Essentials of Medical Pharmacology* 9th ed., Chapter on Urinary Tract Infections.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.